2024 Case Study / Case Report Abstracts
Poster Hall (Exhibit Hall A)
10:00 - 17:30
Open AllClose All
Saturday, September 28
| 1- Brain De-Ironization with Nasal Spray of Iron Chelator in Treatment of Multiple System Atrophy, a Case Trial |
| 14- Role of the Alpha-synuclein Seed Amplification Assay in Parkinson’s Disease Clinical Trials: A Case Report of Multiple System Atrophy Misdiagnosed as Parkinson’s Disease |
| 22- Multiple System Atrophy in a Patient with Normal Pressure Hydrocephalus |
| 30- Lyme disease presenting as a rapidly progressive MSA-C look alike |
| 36- Familial Multiple System Atrophy-Mimics: Importance of Comprehensive Evaluation |
| 37- Heterogeneity of multiple system atrophy with an analysis of the clinical case |
| 38- Posterior Fossa Arachnoid Cysts In Two Patients With Suspected Multiple System Atrophy – Cerebellar Type |
| 50- Paraneoplastic neurological syndrome mimicking a progressive supranuclear palsy: a case series |
| 77- Progressive freezing of gait in atypical parkinsonism. A Possible Progressive Supranuclear Palsy phenotype. |
| 78- PSP: a Clinical Case |
| 80- Pisa Syndrome as an early presenting feature of Corticobasal Ganglionic degeneration [CBGD] |
| 82- Stiff Person Syndrome developing into Corticobasal Syndrome: a case report. |
| 106- Preventing Treatment Disruptions: The Crucial Role of Outpatient Nurses and Multidisciplinary Collaboration in Managing Skin Complications during Foslevodopa/Foscarbidopa Therapy |
| 133- A case of progressive supranuclear palsy followed by dementia with Lewy bodies |
| 135- A Case of Concurrent Wilson Disease and Parkinson Disease |
| 140- Trihexyphenidyl Use in a Parkinsonian Phenotype of Gerstman-Sträussler-Scheinker Syndrome |
| 143- Early-onset Parkinsonism as Presenting Manifestation of CADASIL in a Mexican Woman with NOTCH3 c.1732C>T Pathogenic Variant |
| 145- Perry Syndrome due to a DCTN1 novel variant |
| 149- Pallidotomy as a Therapeutic Option for Patients with Advanced Parkinson's Disease: Case Study |
| 166- Case Report: An Unusual Case of Corticobasal Syndrome |
| 177- Characterization of Autoimmune Parkinsonism. A case series |
| 180- Delayed Parkinsonism as a Delayed Neurological Sequele in Carbon Monoxide Intoxication: A Rare Case Report |
| 182- PSP-Like Syndrome Associated with Dysautonomic Findings as a Presentation of an Anti-Iglon5 Antibody-Related Encephalopathy |
| 183- Giant Aneurysm Causing Parkinsonism and REM Sleep Disorder |
| 190- Atypical Parkinsonism Secondary to Recurrent Deep Vein Thrombosis with Associated Intracranial Dural Fistula |
| 191- Normal pressure hydrocephalus in two Parkinson’s disease patients with deep brain stimulation – co-occurrence or complication |
| 192- Subdural Hematoma Leading to Subacute Secondary Parkinsonism |
| 193- Parkinsonism Associated with Twinkle Gene Mutation |
| 194- Unique Presentation of SPG 15 as Juvenile Levodopa Responsive Parkinsonism: A Case Report |
| 195- Parkinsonism due to Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP) Responsive to Carbidopa/Levodopa |
| 204- The course of cognitive impairment in Parkinson's disease patients with Сovid-19 |
| 212- Wilson Disease Presenting as Rapidly Progressive Dementia |
| 316- Molecular Landscape of Gastrointestinal Dysfunctions in Parkinson's Disease |
| 325- Prevalence of Autonomic Symptoms in Mexican Population with Parkinson's Disease |
| 333- Impairment of REM Sleep Architecture: A Potential Biomarker for Parkinson's Progression |
| 363- Plasma NFL predicting fatigue conversion in early Parkinson’s disease |
| 384- Reduced Thalamic Nuclei Volume May Contribute to Anxiety in Parkinson’s Disease: a 7-Tesla MRI Study |
| 389- Gender-related Cognitive Disparities in Hispanic Patients with Parkinson's Disease: A Cross-Sectional Study |
| 404- Dopamine agonist use and psychotic symptoms in patients with Parkinson’s disease. |
| 413- Cognitive load in a diagnostic electrophysiologic assessment of functional tremor. |
| 416- The Role of Cortisol a Mediator in Influencing Cognitive Function |
| 425- Complete Resolution of Tardive Dystonia After Bilateral Globus Pallidus Interna Deep Brain Stimulation |
| 426- Reversing the irreversible: The application of Deep Brain Stimulation in The Syndrome of Irreversible Lithium Effectuated Neurotoxicity. |
| 429- Quantitative EEG Analysis for Comparing Drug-Induced Parkinsonism and Parkinson's Disease |
| 431- Bistriatal hypermetabolism on 18-FDG PET-CT in tardive dyskinesia |
| 432- Tardive Dystonia Following Risperidone Treatment : A Case Report and Therapeutic Approach |
| 433- Acute dystonic dyskinesias in a patient used fluvoxamine. Case report |
| 434- Central Tremor after CAR-T Cell Therapy: A Case with Neurophysiologic Characterization |
| 437- Prevalence of Movement Disorders in Epilepsy Patients Taking Antiepileptics Drugs in a Tertiary Care Teaching Hospital in Nepal. |
| 438- Comorbid Tardive Dyskinesia (TD) and Restless Leg Syndrome (RLS) |
| 439- Oro-facial Dyskinesia and akathisia following Treatment by Olanzapine |
| 440- Rare Clinical Manifestation of Tardive Dyskinesia In Schizophrenic Patient on Quetiapine and Sertraline: A Case Report |
| 496- Depression and Cognitive Phenotype in Idiopathic Parkinson's Disease without Dementia (IPDWD). Preliminary Results of a Comparative Study of a New Scale ESDEPARK Assessing Depressive Symptomatology Specifically in IPDWD vs a General Geriatric Depression S |
| 504- Enhancing Real-Life Gait Performance in Persons with Parkinson Disease through the Music-Based BeatWalk Application |
| 541- Long-term Physical Exercise on Bone Mineral Density, Balance and Gait in Older Adults with Mild to Moderate Parkinson's Disease |
| 600- Parkinson’s Disease (PD) and predictors of Driving Cessation: Results from a 6-year Longitudinal Study and a systematic review of the literature |
| 603- "Quality of Life of Caregivers Living with a Movement Disorder. A Comprehensive Approach." |
Sunday, September 29
| 641- Essential3: An Innovative Multi-Study Phase 3 Program to Evaluate the Efficacy and Safety of Ulixacaltamide |
| 651- Differential Symptom Cluster Responses and Predictors to Repetitive Transcranial Magnetic Stimulation Treatment in Parkinson’s Disease：A Retrospective Study |
| 765- Assessment of Motor and Non-Motor Alterations Impacting Functionality in Parkinson's Disease Patients |
| 785- Design, synthesis and pharmacological evaluation of 16-pyridylmethylene derivatives of steroidal oximes as antiparkinsonian agents in MPTP-injected mice. |
| 812- Association between Fecal Bile Acids and Levodopa Response in Patients with Parkinson’s Disease |
| 816- Attitudes and Beliefs Towards Medication Burden and Deprescribing in Parkinson Disease |
| 830- Adherence and Persistence Among Patients with Parkinson’s Disease Initiating Istradefylline: 12-Month Follow-Up from US Real-World Data |
| 881- Association between statin use and mortality in Parkinson’s disease |
| 882- A case of malignant Deep Brain Stimulation Withdrawal Syndrome treated with Opicapone |
| 883- ECAP-Controlled Closed-Loop SCS Alleviates Neuropathic Pain and Improves Motor Function in a Patient Suffering from Parkinson’s Disease and Radicular Pain |
| 884- Peri-Electrode Edema after Deep Brain Stimulation Implantation – Case Report and Literature Review |
| 972- Essential Tremor: The Relationship Between Hand Dominance and Tremor Severity by MVPA |
| 975- Neuroimaging Factors Differentially Associated with Pathology and Clinical Presentation |
| 1043- Severity of Motor Symptoms Correlates with Asymmetric Changes in Globus Pallidus Internus and Caudate Nuclei in Parkinson’s Disease |
| 1084- Comparative Study of Whole-Brain Functional Connectivity Patterns in Parkinson's Disease and Essential Tremor: A Resting-State fMRI Study |
| 1090- Alterations in neural processes of cognitive control in asymptomatic heterozygous mutation carriers in the Parkin gene |
| 1092- Emergency pallidotomy in a patient with chorea paralytica in primary hypoparathyroidism |
| 1093- Cognitive Outcome in Pantothenate Kinase-Associated Neurodegeneration (PKAN) Treated with Deep Brain Stimulation (DBS):Case Report |
| 1094- One-Year Outcomes of Multitarget Thalamic and Pallidal Deep Brain Stimulation in Unilateral Dystonia |
| 1095- Deep Brain Stimulation (DBS) Improves Parkinsonism Caused by Osmotic Demyelination Syndrome (ODS) |
| 1096- Pregnancy in Dystonia or Tourette’s patients with DBS. Eleven New Cases and a Review of the Literature. |
| 1099- Real-World Clinical and Safety Outcomes from a Prospective, Multicenter Deep Brain Stimulation Registry of Essential Tremor Patients |
| 1101- Impact on quality of life and nonmotor symptoms of unilateral magnetic resonance-guided focused ultrasounds (FUS) thalamotomy in patients with essential tremor. |
| 1102- Deep Brain Stimulation of bilateral ventral intermediate nucleus in a patient with spinocerebellar ataxia type 12 |
| 1109- Botulinum Toxin and Deep Brain Stimulation in Dystonia |
| 1115- Unveiling the Long-term Impact of Unilateral Vim DBS in Essential Tremor |
| 1119- Deep brain stimulation of globus pallidus internus for monogenic dystonia |
| 1120- GNAO1-related Neurodevelopmental Disorder with Involuntary Movements Inducing a Dyskinetic Status |
| 1121- Acute Reversible Laughter with Globus Pallidus Interna Stimulation |
| 1122- Vim DBS for Post-Stroke Tremor: A Case Report |
| 1123- Deep brain stimulation of bilateral ventral intermediate nucleus in patients with neuronal intranuclear inclusion disease |
| 1125- Intraoperative venous air embolism in the semi-sitting position in functional neurosurgery |
| 1127- The Characteristics and Management of Patients with Dystonia Referred for The Troubleshooting of Deep Brain Stimulation Therapy: A Single Center Experience |
| 1128- Holmes Tremor Treated with Pallidal Stimulation |
| 1168- Effect of Target Selection on Mood, Pain, and Medications after DBS in PD |
| 1173- Functional connectivity enhances prediction of STN DBS motor outcomes |
| 1176- Longevity of Motor Benefit Achieved with Deep Brain Stimulation (DBS) of the Subthalamic Nucleus (STN) in a Single Center Cohort at the Decade Mark Post-Implantation. |
| 1181- Early Outcomes Support use of a Remote Cross-Border Surgical Centre for Deep Brain Stimulation in Parkinson’s Disease |
| 1186- The Challenges of Adaptive Deep Brain Stimulation: A Delphi Panel Study |
| 1254- Identification of Fall Risk in Patients with Parkinson's Disease Through Telemonitoring |
| 1259- Digital health technology (DHT) derived features as sensitive measures of disease progression in early Parkinson’s disease under stable dopaminergic treatment |
Monday, September 30
| 1280- Spectrum of polysomnographic abnormalities in a cohort of sporadic late onset ataxia patients |
| 1282- White Matter Tractography in Spinocerebellar Ataxia type 1 and 2 in comparison with Healthy Controls |
| 1283- Variant Ataxia Telangiectasia: A Novel ATM Gene Mutation With Disabling Tremor and Response to Deep Brain Stimulation |
| 1284- Novel Partial Gene Deletion in CaCNA1A Presenting with Gait Ataxia, Vertigo, and Abnormal Eye Movements |
| 1286- Increased Risk of Suicidal Ideation in Patients with Spinocerebellar Ataxias |
| 1289- Spinocerebellar ataxia type 2 (SCA2) and Seizures: Is There a Correlation? |
| 1291- Progressive Myoclonic Ataxia: Neuroinflammation and Autoantibodies Against Inhibitory Synapses and Herpes Viruses |
| 1294- Pulmonary Dysfunction in Friedreich's Ataxia (FRDA) |
| 1298- Association of expanded CAG repeat with autonomic function in Spinocerebellar Ataxia Type-2 (SCA-2) |
| 1300- Clinical and Genetic Profile of Spinocerebellar Ataxias in a Tunisian Cohort |
| 1302- Prevalence of Heterozygous ATP7B Mutation in Patients with Movement Symptoms |
| 1305- Electrophysiological study of 122 Tunisian patients with autosomal recessive cerebellar ataxia |
| 1307- NGS diagnosis rate in a combined cerebellar ataxia and spastic paraplegia series from southern Spain |
| 1311- Substantia Nigra Degeneration In Spinocerebellar Ataxia 2 And 7 Using Neuromelanin-Sensitive Imaging |
| 1312- Ataxia, tremor, fasciculations and hemiparesis in a GBA1 heterozygous female carrier |
| 1314- Oculomotor Biomarkers for Cerebellar Ataxia and Severity in Smooth Pursuit |
| 1316- Alterations in the Daily Living Gait and Mobility during the Day and Night among Individuals with Cerebellar Ataxia, SCA3: An Exploratory Study |
| 1317- Spinocerebellar Ataxia Type 49 presenting with Early onset Dystonia-Ataxia in an Indian Female |
| 1324- Predicting Disease Severity in Friedreich's Ataxia through Wearable Monitoring and Machine Learning. |
| 1325- CAPRIN1 defect: a new severe neurodegenerative disorder with childhood dementia, myoclonus-ataxia, and sensorimotor neuropathy |
| 1328- paraneoplastic cerebellar ataxia: a rare cause of late-onset ataxia |
| 1330- Effects of Transpinal Magnetic Stimulation (TsMS) in Patients Diagnosed with Spinocerebellar Ataxia 3 (SCA 3) |
| 1331- Seminoma resulting in rapidly progressive cerebellar syndrome with associated dual positive kelch-like protein 11 (KLHL11) IgG and leucine zipper 4 (LUZP4)–immunoglobulin G (IgG) antibodies. |
| 1332- Superficial siderosis; a case review |
| 1333- Diagnostic challenges with novel SCA variants: A case of STUB1 mutation |
| 1334- Spastic Ataxia Associated with Congenital Myasthenia Related to the VAMP1 Gene: Report of an Affected Family in Brazil. |
| 1335- Transcranial Direct Current Stimulation and Neurofunctional Physical Therapy Improves Motor and Cognitive Symptoms in a Patient with Type 1 Spinocerebellar Ataxia – A Case Report |
| 1336- Movement disorders secondary to neurocysticercosis: a case report from Bolivia |
| 1338- Volatile solvent abuse and Cerebellar ataxia: A case series |
| 1340- Friedreich’s ataxia: A descriptive study of a Tunisian cohort |
| 1341- Progressive cerebellar ataxia in primary Sjögren’s syndrome: a case report |
| 1343- A study on the phenomenological analysis of Spinocerebellar Ataxia type 12 revealing a dystonic imprint |
| 1350- Ektacytometry in Neuroacanthocytosis |
| 1351- A Novel Mutation of NKX2-1 Gene: A Rare Presentation of Chorea |
| 1355- The clinical features, neuroimagings and outcomes of diabetic striatopathy: a retrospective study at tertiary hospital in Vietnam |
| 1358- Spectrum of Non-HD Hereditary Chorea- Case Series from An Indian Movement Disorder Centre |
| 1360- A Rare Case of Hemicorea Secondary to Giant Perivascular Space: A Case Report |
| 1361- Clonazepam as First-Line Therapy for Post-Hypoxic Chorea: A Case Report and Discussion |
| 1363- Chorea Acanthocytosis Misdiagnosed as Functional Movement Disorder |
| 1364- Bilateral Fronto-Temporal Lobar Atrophy: An Atypical Magnetic Resonance Imaging Finding in Neuroacanthocytosis |
| 1365- Hyperkinetic Movements Related to COVID-19 Vaccine |
| 1366- Fahr's Disease Presenting as Chorea: A Rare Case Report |
| 1367- Reversible Hemichorea-Hemiballismus-Hemifacial Spasm in Diabetic Striatopathy |
| 1368- Choreoacanthocytosis: The First Genetically Confirmed Cases From Algeria |
| 1369- Cortical Pencil Lining in Brain MRI of a Patient with Chorea and Hepatic Cirrhosis |
| 1370- Acute Chorea in The Emergency Department Related to Systemic Lupus and Antiphospholipid Syndrome: A Case Report |
| 1371- Diabetic striatopathy with stroke - like symptoms: A case report |
| 1372- Severe chorea, ballistic and dystonic movement disorder due to intracerebral hemorrhage in subthalamic nucleus |
| 1379- The Impact of Standardized Recommendations on the Management of Initial and Refractory Pediatric Status Dystonicus |
| 1382- Deep Brain Stimulation in Dystonia: Investigating Differential Response by Dystonia Distribution |
| 1388- Do Lower Doses of Botulinum Neurotoxin Type-A Offer a Longer Duration of Effect and Superior Efficacy in Patients with Cervical Dystonia? |
| 1404- Real-World Diagnosis of Chronic Migraine in Patients With Cervical Dystonia Analyzed by Botulinum Neurotoxin Treatment Exposure: an Epidemiologic Perspective |
| 1406- KMT2B-Related Dystonia And DBS: Tertiary Center Experience |
| 1407- Clinical Outcomes and Local Field Potential Characteristics in Bilateral GPi DBS in 2 cases of X-Linked Dystonia Parkinsonism |
| 1409- Clinical Characteristics and Management Practices of Pediatric Status Dystonicus |
| 1410- Genetic Variant in the VPS16 Gene in a 44-year-old Patient with Generalized Dystonia |
| 1417- Cervical dystonia after cerebellar stroke and medullary hemorrhage |
| 1418- Challenges in Wilson disease management in a resource-limited country: a case report from a tertiary center |
| 1420- Oromandibular Dystonia in Hashimoto Encephalopathy: An Unusual Association Not To Miss |
| 1422- Expanding the concept of “occupational dystonia”: data from the Italian Dystonia Registry |
| 1431- Increased cerebellar grey matter in writer’s cramp patients: a morphometric signature of symptom compensation |
| 1435- Writing dysfluency associates with basal ganglia network dysfunction in writer’s cramp dystonia |
| 1466- Treatment Effect Sizes of Once-Daily Valbenazine for Tardive Dyskinesia and for Chorea Associated with Huntington’s Disease: A Post-Hoc Analysis of Phase 3 Clinical Trial Data |
| 1484- The Spectrum of Presenting Phenotypes in Childhood Onset Huntingtons Disease |
| 1486- Closed-Loop Spinal Cord Stimulation: A Case Report on a Novel Therapeutic Approach for Post-Hypoxic Myoclonus |
| 1487- Treatment of Post-hypoxic Myoclonus using Bilateral Subthalamic Nuclei Deep Brain Stimulation |
| 1490- Cortical myoclonus in DHDDS: the multifaced presentation of a single movement disorder |
| 1492- Mechanism Study of Familial Cortical Myoclonic Tremor with Epilepsy Type 1 Caused by Pentanucleotide Repeat Expansion in the SAMD12 Gene |
| 1493- Childhood onset progressive myoclonus and ataxia in a patient with novel TBC1D2B gene mutation |
| 1502- Benzodiazepines in the Management of Restless Legs Syndrome: A Systematic Review and Meta-Analysis |
| 1522- Ultrasound Assessment of Collagen Content in Contracted and Non-contracted Muscle Areas: A Comparative Study |
| 1533- Contribution to Efficacy by Active Metabolites of Suvecaltamide in a Preclinical Rat Model of Essential Tremor |
| 1546- Dentato-Rubro-Thalamic Tract Deep Brain Stimualtion for Essential Tremor: Stimulation Parameters and Clinical Outcomes |
| 1559- Prevalence of Phosphorylated Alpha-Synuclein in Skin Biopsies of Essential Tremor Patients |
| 1564- Sleep profiles in patients with Essential Tremor and Essential Tremor Plus: Polysomnography Insights |
| 1573- Evaluating the Effect of Myofascial Release on Parkinson's Related Tremor |
| 1576- Is essential tremor-plus phenotype a prodromal phase of Parkinson’s disease ? |
| 1580- Application of Neurophysiology in the Clinical Evaluation of Pediatric and Adolescent Patients with Tremor |
| 1581- Movement Disorders Associated with Infectious Encephalitis in Pediatric Patients |
| 1587- Identification and Screening of Candidate Genes for Paroxysmal Movement Disorders by Next Generation Sequencing Approach for Developing Molecular Diagnostics. |
| 1589- Improving Work Up amongst Patients with Rare Movement Disorders according to Diagnostic Yield Findings– Update from Single Center Neurogenetic Clinic |
| 1595- Three-Year Progression of the Postural Control Alterations in Hereditary Spastic Paraplegias |
| 1597- Expanding the phenotypic spectrum of movement disorders in 22q11.2 deletion syndrome |
| 1598- A Novel SLC9A1 Mutation Associated with Cerebellar Ataxia and Sensorineural Hearing Loss |
| 1599- Parkinsonism in combined Fragile X and XYY Syndromes: A Case Report |
| 1600- Clinico- radiological profile of four patients with CSF1R- related leukoencephalopathy: A case series from India |
| 1604- Intermediate Expansion of MARCHF6 causes FAME3 without Epilepsy |
| 1606- Validation of Inertial Measurement Units and an application compared with the reference system to assess the gait in hereditary spastic paraplegia |
| 1607- OPTN gene associated with corticobasal syndrome: a novel multi-exon deletion and literature review |
| 1619- Association of Gaucher-related and Parkinson’s-private GBA1 variants with progression of PD: A longitudinal mixed model analysis. |
| 1629- Disease Progression in Patients with PLA2G6-related Parkinsonism: A Longitudinal Study |
| 1636- Differences in Oculometric Measures between Patients with LRRK2-associated and Idiopathic Parkinson’s Disease |
| 1668- Genetic Analysis of Mendelian mutations in A Large Chinese Early-onset and Familial Parkinson’s Disease |
| 1681- The Black and African American Connections to Parkinson’s Disease Study |
| 1692- The association of Severity and Monogenetic Subgroups in Parkinson's Disease |
| 1693- 7year followup of Asia’s first case of sporadic ATP6AP2 Mutation: α-synucleinopathy or tauopathy? |
| 1694- Expanding Phenotype of LRRK2 G2019S Mutation: Case Description of Two Sisters Showing Peculiar Phenomenological Traits |
| 1695- A Case of Paradoxical Gait Response to Levodopa in Parkin-Gene-Related Early-Onset Parkinson's Disease |
| 1696- Adding Parkinsonism to the Phenotypic Spectrum of FIG4-related diseases |
| 1697- A new phenotype-genotype correlation for FIG4 gene and Parkinson's disease |
| 1700- Novel ASO Targeting IGHMBP2 Cryptic Splice Variant: Efficacy and Safety |
| 1703- Wilson's Disease : A Senegalese Series of Seven Patients Followed at Pikine National Hospital Centre (Dakar-Senegal) |
| 1704- DPPX Autoimmune Encephalitis Associated with Severe Multifocal Dystonia. |
| 1705- A Patient with Overlapping SPG7 mutation and MERRF |
| 1712- Association between Hyperglycemic Crisis Severity and Movement Disorders in Hispanic Patients with De Novo Hyperglycemia: A Cross-Sectional Study |
| 1725- Mutation of the ATP5F1A gene associated with dystonia, spasticity, myoclonus, cognitive impairment and epilepsy – a rare case report of a patient |
| 1727- Movement Disorders in Cerebrotendinous Xanthomatosis |
| 1729- Movement Disorders in De Novo Hyperglycemic Crisis: Insights from a Clinical Case Series |
| 1730- A Unique case of Ataxia, Neuropathy, and chronic cough: CANVAS |
| 1731- Startle Reflex in CTNNB1 Mutations: A diagnostic Clue |
| 1732- Dopa-responsive ataxia with compound heterozygous variants in MRE11 |
| 1733- Phenotypic variability of mitochondrial tRNA Ser(UCN) gene [MTTS1] mutation: First report from India |
| 1734- PMM2 mutation |
| 1735- Spastic Ataxia and Motorneuron disease as possible manifestations of ATP13A2 (PARK 9) variants |
| 1736- Phenomenology of Coenzyme Q10-deficiency Spinocerebellar Ataxia: Case Description Of Two Siblings And New Therapeutic Perspectives |
| 1743- Complexity of fractal patterns in motor cortical oscillatory activity in rodent models of Parkinson disease |
| 1754- Clinical, Neurophysiological, and Biological Insights into Levodopa-Induced Dyskinesias |
| 1764- Correlation of Neural Sensing with the Volume of Neural Activation within the Desired Patient-Specific Anatomical Target in Deep Brain Stimulation for Parkinson’s Disease |
| 1765- Levels of change in interleukin-6 levels according to clinical forms of Parkinson's disease in patients with and without Covid-19 |
| 1770- Quantification of an Upper Limb Rigidity Network in Parkinson Disease |
| 1821- Pregnancy and delivery in women with Parkinson’s disease: A case series |
| 1844- Free-Viewing Eye Tracking and the Effect of Levodopa in Parkinson’s Disease |
| 1845- Evaluation of unsteadiness in patients with dystonia |
| 1849- Apraxia of eyelid opening in patients with movement disorders |
| 1862- Engage, Educate and Empower: Parkinson’s Research Advocates from the Black and African American Community |
| 1880- Behind the Prison Gates - Creating a nurse led Parkinson’s healthcare pathway at HMP Dartmoor Prison, UK. |
| 1889- Antibody-mediated movement disorders: a single-centre retrospective study |
| 1901- Movement Disorders in the Emergency:New Insights |
| 1905- Tremors Vs. Tremors: the first music album from Parkinson’s tremors |
| 1909- Seeking Traditional Healers in Movement Disorders: a pilot study in two African Countries |
| 1915- Demographics of Botulinum toxin therapy population representative to demographics in Essex County, USA |
| 1916- Dandy-Walker syndrome. A case study. |
| 1917- Wilson's Disease About A Complex Case |
| 1922- PD Young Ambassadors: A Peer-led, Community-Based Intervention to Raise PD Awareness in the Hispanic Communities of Chicago. |
| 1923- Adult Onset Spastic Paraplegia in TUBB4A Leukodystrophy |